36
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Management of Glaucoma-Related Dry Eye Disease with Intense Pulsed Light: A Randomized Control Study

, , , , , , , & ORCID Icon show all
Pages 2061-2072 | Received 30 Mar 2024, Accepted 10 Jul 2024, Published online: 15 Jul 2024

References

  • Galor A, Feuer W, Lee DJ, et al. Prevalence and risk factors of dry eye syndrome in a United States Veterans Affairs population. Am J Ophthalmol. 2011;152(3). doi:10.1016/j.ajo.2011.02.026
  • Dana R, Bradley JL, Guerin A, et al. Estimated prevalence and incidence of dry eye disease based on coding analysis of a large, all-age United States Health Care System. Am J Ophthalmol. 2019:202. doi:10.1016/j.ajo.2019.01.026
  • Wang TJ, Wang IJ, Hu CC, Lin HC. Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol. 2012;90(7). doi:10.1111/j.1755-3768.2010.01993.x
  • Ma J, Pazo EE, Zou Z, Jin F. Prevalence of symptomatic dry eye in breast cancer patients undergoing systemic adjuvant treatment: a cross-sectional study. Breast. 2020;53. doi:10.1016/j.breast.2020.07.009
  • Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–365. doi:10.1016/j.jtos.2017.05.003
  • Nijm LM, Schweitzer J, Blackmore JG. Glaucoma and dry eye disease: opportunity to assess and treat. Clin Ophthalmol. 2023;17:3063–3076. doi:10.2147/OPTH.S420932
  • Leite MT, Sakata LM, Medeiros FA. Managing glaucoma in developing countries. Arq Bras Oftalmol. 2011;74(2). doi:10.1590/S0004-27492011000200001
  • Lee SY, Wong TT, Chua J, Boo C, Soh YF, Tong L. Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity. Eye. 2013;27(10):1142–1150. doi:10.1038/eye.2013.144
  • Mastropasqua R, Agnifili L, Mastropasqua L. Structural and molecular tear film changes in glaucoma. Curr Med Chem. 2018;26(22). doi:10.2174/0929867325666181009153212
  • Roberti G, Tanga L, Manni G, et al. Tear film, conjunctival and corneal modifications induced by glaucoma treatment. Curr Med Chem. 2019;26(22). doi:10.2174/0929867326666190517111823
  • Bourne RRA, Kaarniranta K, Lorenz K, Traverso CE, Vuorinen J, Ropo A. Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label Phase IV study. BMJ Open. 2019;9(4):e024129. doi:10.1136/BMJOPEN-2018-024129
  • Wolfram C, Stahlberg E, Pfeiffer N. Patient-reported nonadherence with glaucoma therapy. J Ocul Pharmacol Ther. 2019;35(4):223–228. doi:10.1089/jop.2018.0134
  • Kim DW, Seo JH, Lim SH. Evaluation of ocular surface disease in elderly patients with glaucoma: expression of matrix metalloproteinase-9 in tears. Eye. 2020;35(3):892–900. doi:10.1038/s41433-020-0993-y
  • Razeghinejad R, Lin MM, Lee D, Katz LJ, Myers JS. Pathophysiology and management of glaucoma and ocular hypertension related to trauma. Surv Ophthalmol. 2020;65(5). doi:10.1016/j.survophthal.2020.02.003
  • Wong TT, Zhou L, Li J, et al. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. Invest Ophthalmol Vis Sci. 2011;52(10). doi:10.1167/iovs.10-6532
  • Fan Q, Pazo EE, You Y, et al. Subjective quality of vision in evaporative dry eye patients after intense pulsed light. Photobiomodul Photomed Laser Surg. 2020:photob.2019.4788. doi:10.1089/photob.2019.4788
  • Li L, Chen J, Qin G, et al. Tear film lipid layer changes following combined effect of heated eye mask with intense pulsed light therapy for evaporative dry eye: a randomized control study. Photobiomodul Photomed Laser Surg. 2023;41(8):435–444. doi:10.1089/PHOTOB.2023.0051
  • Babilas P, Schreml S, Szeimies RM, Landthaler M. Intense pulsed light (IPL): a review. Lasers Surg Med. 2010;42(2). doi:10.1002/lsm.20877
  • Qin G, Chen J, Li L, et al. Efficacy of intense pulsed light therapy on signs and symptoms of dry eye disease: a meta-analysis and systematic review. Indian J Ophthalmol. 2023;71(4):1316–1325. doi:10.4103/IJO.IJO_2987_22
  • Wellik SR. Glaucoma and dry eye syndrome: double trouble. Dry Eye Dis. 2023;147–152. doi:10.1016/B978-0-323-82753-9.00009-6
  • Mei Kong X, Qing Zhu W, Xu Hong J, Huai Sun X. Is glaucoma comprehension associated with psychological disturbance and vision-related quality of life for patients with glaucoma? A cross-sectional study. BMJ Open. 2014;4:4632. doi:10.1136/bmjopen-2013
  • Martinez-de-la-casa JM, Oribio-Quinto C, Milans-Del-Bosch A, et al. Intense pulsed light-based treatment for the improvement of symptoms in glaucoma patients treated with hypotensive eye drops. Eye Vis. 2022;9(1):12. doi:10.1186/s40662-022-00284-4
  • Uchino Y, Uchino M, Dogru M, Ward S, Yokoi N, Tsubota K. Changes in dry eye diagnostic status following implementation of revised Japanese dry eye diagnostic criteria. Jpn J Ophthalmol. 2012;56(1):8–13. doi:10.1007/s10384-011-0099-y
  • Zhang XM, Yang LT, Zhang Q, et al. Reliability of Chinese web-based ocular surface disease index questionnaire in dry eye patients: a randomized, crossover study. Int J Ophthalmol. 2021;14(6). doi:10.18240/ijo.2021.06.07
  • Guarnieri A, Carnero E, Bleau AM, Alfonso-Bartolozzi B, Moreno-Montañés J. Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients. Int Ophthalmol. 2020;40(3):741–751. doi:10.1007/S10792-019-01236-Z/METRICS
  • Mataftsi A, Koutsimpogeorgos D, Brazitikos P, Ziakas N, Haidich AB. Is conversion of decimal visual acuity measurements to logMAR values reliable? Graefes Arch Clin Exp Ophthalmol. 2019;257(7):1513–1517. doi:10.1007/s00417-019-04344-9
  • Karmiris E, Tsiripidis K, Gartaganis PS, et al. Comparison of intraocular pressure obtained by Goldmann applanation tonometer, Corvis ST and an airpuff tonometer in healthy adults. Eur J Ophthalmol. 2021. doi:10.1177/11206721211069227
  • Huang J, Maram J, Tepelus TC, Sadda SR, Chopra V, Lee OL. Comparison of noncontact specular and confocal microscopy for evaluation of corneal endothelium. Eye Contact Lens. 2018;44:S144–S150. doi:10.1097/ICL.0000000000000362
  • Lee R, Yeo S, Aung HT, Tong L. Agreement of non-invasive tear break up time measurement between Tomey RT-7000 Auto Refractor-Keratometer and Oculus Keratograph 5M. Clini Ophthalmol. 2016;10:1785–1790. doi:10.2147/OPTH.S110180
  • Hosaka E, Kawamorita T, Ogasawara Y, et al. Interferometry in the evaluation of precorneal tear film thickness in dry eye. Am J Ophthalmol. 2011;151(1):18–23.e1. doi:10.1016/j.ajo.2010.07.019
  • Yeh TN, Lin MC. Repeatability of meibomian gland contrast, a potential indicator of meibomian gland function. Cornea. 2019;38(2):256. doi:10.1097/ICO.0000000000001818
  • Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003;1(3):107–126. doi:10.1016/S1542-0124(12)70139-8
  • Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmol. 2008;115(5):911–915. doi:10.1016/J.OPHTHA.2007.06.031
  • Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol. 1996;122(6):818–824. doi:10.1016/S0002-9394(14)70378-2
  • Chen J, Qin G, Li L, et al. The combined impact of intense pulsed light combined and 3% diquafosol ophthalmic solution on evaporative dry eye: a randomized control study. Ophthalmol Ther. 2023:1–13. doi:10.1007/S40123-023-00784-Z/TABLES/3
  • Dell SJ, Gaster RN, Barbarino SC, Cunningham DN. Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol. 2017;11:817–827. doi:10.2147/OPTH.S130706
  • Chen J, Qin G, Li L, et al. Protocol for a parallel assignment prospective, randomised, comparative trial to evaluate the safety and efficacy of intense pulsed light (IPL) combined with 3% diquafosol (DQS) ophthalmic solution in dry eye syndrome. BMJ Open. 2023;13(8):e073055. doi:10.1136/BMJOPEN-2023-073055
  • Nijm LM, De Benito-Llopis L, Rossi GC, Vajaranant TS, Coroneo MT. Understanding the dual dilemma of dry eye and glaucoma: an international review. Asia Pac J Ophthalmol. 2020;9(6):481–490. doi:10.1097/APO.0000000000000327
  • Tsai J, Derby E, Holland E, Cornea AK. Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea. 2006;25(5):530–532. doi:10.1097/01.ico.0000220776.93852.d9
  • Qin G, Chen J, Li L, et al. Managing severe evaporative dry eye with intense pulsed light therapy. Ophthalmol Ther. 2023:1–13. doi:10.1007/S40123-023-00649-5/TABLES/4
  • Yang L, Pazo EE, Zhang Q, et al. Treatment of contact lens related dry eye with intense pulsed light. Cont Lens Anterior Eye. 2021:101449. doi:10.1016/J.CLAE.2021.101449
  • Ding J, Sullivan DA. Aging and dry eye disease. Exp Gerontol. 2012;47(7):483–490. doi:10.1016/J.EXGER.2012.03.020
  • Song Y, Yu S, He X, et al. Tear film interferometry assessment after intense pulsed light in dry eye disease: a randomized, single masked, sham-controlled study. Cont Lens Anterior Eye. 2021:101499. doi:10.1016/J.CLAE.2021.101499
  • Soriano D, Ferrandez B, Mateo A, Polo V, Garcia-Martin E. Meibomian gland changes in open-angle glaucoma users treated with topical medication. Optom Vis Sci. 2021;98(10):1177–1182. doi:10.1097/OPX.0000000000001782
  • Quaranta L, Novella A, Tettamanti M, Pasina L, Weinreb RN, Nobili A. Adherence and persistence to medical therapy in glaucoma: an overview. Ophthalmol Ther. 2023;12(5):2227–2240. doi:10.1007/S40123-023-00730-Z
  • Pérez-García P, Burgos-Blasco B, Morales-Fernández L, et al. Prescription trends for preservative free glaucoma medication in a public health system. Eur J Ophthalmol. 2024;34(1):193–203. doi:10.1177/11206721231170034
  • Park MH, Kang KD, Moon J. Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study. Jpn J Ophthalmol. 2013;57(1):47–56. doi:10.1007/S10384-012-0188-6
  • Hu JG, Dang VT, Chang DH, et al. Performance of a translucent activator for LipiFlow Vectored Thermal Pulse (VTP) Treatment of Meibomian Gland Dysfunction. Clin Ophthalmol. 2022;16:963–971. doi:10.2147/OPTH.S354738